Page 6 - Lakes Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Important steps agreed to support long-term employment in Ulverston Artist’s impressions of Lakes BioScience’s biopharmaceuticals site in Ulverston Important steps have been agreed that will support long term-employment in Ulverston after one of the town’s biggest employers revealed it would be closing its site earlier this year. GlaxoSmithKline (GSK) revealed in February it would be closing its site in the town by 2025, with operations being transferred to German firm Sandoz. During the transfer period, GSK’s manufacturing operations will continue, and there is no immediate ...

THE MP has appealed to the Prime Minister calling on his support to secure plans for Lakes BioScience at the GSK Site in Ulverston. Simon Fell, MP for Barrow and Furness, has penned a letter to Prime Minister Boris Johnson appealing for his backing to secure the site for Lakes BioScience which he believes will be a 'win-win' for the community'. Earlier this month, GSK announced it would shutter their facilities in Ulverston by 2025 after 75 years of operation following the sale of their antibiotics business to Sandoz. Mr Fell said: "We are asking the UK Government to press GSK into ba...

BARROW and Furness MP has urged the Prime Minister to support plans for the Lakes BioScience at the GSK Site in Ulverston.

Column by Barrow and Furness MP Simon Fell:

GSK in Ulverston Barrow MP Simon Fell has called a public meeting to discuss the future of the GSK site in Ulverston. Last week, the pharmaceuticals giant announced it is to close the cephalosporin division of its business as part of a $350 million sale to another pharmaceuticals firm, Novartis’ Sandoz. GSK confirmed that it will continue to produce the antibiotic Zinnat at the Ulverston site until 2025. An emergency taskforce meeting was convened by Mr Fell took place on Wednesday. Directors and senior management from GSK, union representatives and councillors from South Lakeland Distri...